September domestic air traffic rises 46.5% YoY to 103.55 lakh passengers

The air traffic, however, is lower than pre-COVID levels. In September 2019, domestic airlines flew 115.33 lakh passengers

Moneycontrol News

October 19, 2022 / 12:43 IST

Representative Image

India's domestic air traffic rose 46.5 percent year-on-year to 103.55 lakh passengers in September against 101.16 lakh passengers in the previous month, data released by the Directorate General of Civil Aviation on October 19 shows.

During January-September 2022, domestic airlines carried 874.24 lakh passengers, up from 531.11 lakh during the year-ago period, registering an annual growth of 64.61 percent, the civil aviation regulator said.

Also Read: August domestic air traffic rises 51% Y-o-Y to 101.16 lakh passengers

The air traffic, however, was still lower than pre-COVID levels. In September 2019, domestic airlines flew 115.33 lakh passengers.

The market share of India's largest airline IndiGo remained unchanged from August at 57.7 percent, with the carrier flying 59.72 lakh passengers in September.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show